World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
52796
World Ranking
7217
National Ranking
106

Bruno Sangro publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Bruno Sangro sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 582 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Bruno Sangro D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Bruno Sangro sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 103 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Bruno Sangro is affiliated with the University of Navarra in Spain and focuses their research within the field of Medicine, particularly on hepatology. Their work encompasses the study of liver diseases, cancer immunotherapy, and oncology-related topics, with a significant emphasis on hepatocellular carcinoma (HCC).

Their recent research contributions include several notable papers:

  • BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update (2021), published in Journal of Hepatology
  • Advances in immunotherapy for hepatocellular carcinoma (2021), published in Nature Reviews Gastroenterology & Hepatology
  • Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma (2022), published in NEJM Evidence
  • Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib (2020), published in JAMA Oncology
  • Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines (2021), published in Annals of Oncology

Their frequent coauthors include:

  • Patrizia Burra
  • Frank Tacke
  • Masatoshi Kudo
  • Vlad Ratziu
  • Paolo Angeli

Prominent venues where they have published frequently are:

  • Journal of Hepatology
  • Journal of Clinical Oncology
  • Annals of Oncology
  • CardioVascular and Interventional Radiology
  • JHEP Reports

Their research spans multiple subfields including:

  • Hepatology
  • Oncology
  • Epidemiology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology

Main topics of their work cover:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver Disease Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Pancreatic and Hepatic Oncology Research
  • Hepatitis C virus research
  • Colorectal Cancer Treatments and Studies

Best Publications

  • Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

    Anthony B. El-Khoueiry;Bruno Sangro;Thomas Yau;Todd S. Crocenzi

  • BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system. The 2022 update.

    M. Reig;A. Forner;J. Rimola;J. Ferrer-Fábrega

  • Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade

    Philip J. Johnson;Sarah Berhane;Chiaki Kagebayashi;Shinji Satomura

  • Advances in immunotherapy for hepatocellular carcinoma

    Bruno Sangro;Pablo Sarobe;Sandra Hervás-Stubbs;Ignacio Melero

  • Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial.

    Thomas Yau;Yoon Koo Kang;Tae You Kim;Anthony B. El-Khoueiry

  • A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.

    Bruno Sangro;Carlos Gomez-Martin;Manuel de la Mata;Mercedes Iñarrairaegui

  • Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

    María Reig;Zoe Mariño;Christie Perelló;Mercedes Iñarrairaegui

  • CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)

    T. Yau;J.W. Park;R.S. Finn;A.-L. Cheng

  • Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions.

    Luigi Bolondi;Andrew Burroughs;Jean François Dufour;Peterr R. Galle

  • Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

    Bruno Sangro;Livio Carpanese;Roberto Cianni;Rita Golfieri

  • Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

    J.-L. Raoul;B. Sangro;A. Forner;V. Mazzaferro

  • Phase I Trial of Intratumoral Injection of an Adenovirus Encoding Interleukin-12 for Advanced Digestive Tumors

    Bruno Sangro;Guillermo Mazzolini;Juan Ruiz;Maite Herraiz

  • Immunological landscape and immunotherapy of hepatocellular carcinoma

    Jesús Prieto;Ignacio Melero;Bruno Sangro

  • New therapies for hepatocellular carcinoma.

    M A Avila;C Berasain;B Sangro;J Prieto

  • Liver disease induced by radioembolization of liver tumors: description and possible risk factors.

    Bruno Sangro;Belen Gil-Alzugaray;Javier Rodriguez;Iosu Sola

  • Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application.

    C. Fillat;M. Carrio;A. Cascante;B. Sangro

  • Radioembolization for hepatocellular carcinoma.

    Bruno Sangro;Mercedes Iñarrairaegui;Jose I. Bilbao

  • Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study

    Robin Kate Kelley;Bruno Sangro;William Harris;Masafumi Ikeda

  • Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines.

    A. Vogel;E. Martinelli;A. Cervantes;I. Chau

  • Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma

    Bruno Sangro;Ignacio Melero;Samir Wadhawan;Richard S Finn

Frequent Co-Authors

Jesús Prieto
Jesús Prieto University of Navarra
Ignacio Melero
Ignacio Melero University of Oxford
Masatoshi Kudo
Masatoshi Kudo Kindai University
Jordi Bruix
Jordi Bruix University of Barcelona
Tim Meyer
Tim Meyer University College London
Matías A. Avila
Matías A. Avila University of Navarra
Winnie Yeo
Winnie Yeo Chinese University of Hong Kong
Jose J.G. Marin
Jose J.G. Marin University of Salamanca
Riad Salem
Riad Salem Northwestern University
Yoon-Koo Kang
Yoon-Koo Kang Asan Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The healthcare field offers a variety of pathways for students interested in medicine but seeking flexible or alternative educational options. For those aspiring to begin their healthcare journey quickly, exploring easiest rn program to get into can be a strategic starting point. These nursing programs typically have more accessible admission requirements, helping you enter the profession sooner.

If you’re interested in the administrative side of healthcare, there are reputable medical billing and coding schools online that provide the flexibility to study from home and financial aid options. This career can offer stable opportunities without direct patient care.

For those concerned about standardized testing, some nursing school without teas test requirements may appeal, allowing you to focus on your studies rather than exam prep.

Lastly, fast-tracking your leadership career is possible by enrolling in accelerated healthcare programs, which can provide advanced credentials in a shorter timeframe.

Exploring these online degree options can help you find a medical or healthcare pathway that fits your strengths, interests, and lifestyle.

Best Scientists Citing Bruno Sangro

Trending Scientists

Recently Published Articles